Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8541)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2017 (publication date) through Jul 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sezaki T, Hirata Y, Hagiwara T, Kawamura YI, Okamura T, Takanashi R, Nakano K, Tamura-Nakano M, Burkly LC, Dohi T. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice. World J Gastroenterol 2017; 23(13): 2294-2307 [PMID: 28428709 DOI: 10.3748/wjg.v23.i13.2294] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i13/2294.htm |
| Number | Citing Articles |
| 1 |
Ourania S. Kotsiou, Konstantinos I. Gourgoulianis, Sotirios G. Zarogiannis. IL-33/ST2 Axis in Organ Fibrosis. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02432
|
| 2 |
Guanglei Hu, Weihui Zeng, Yumin Xia. TWEAK/Fn14 signaling in tumors. Tumor Biology 2017; 39(6): 101042831771462 doi: 10.1177/1010428317714624
|
| 3 |
Xifu Cheng, Famin Yang, Yuanheng Li, Yuke Cao, Meng Zhang, Jiameng JI, Yuxiao Bai, Qing Li, Qiongfang Yu, Dian Gao. The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer. Aging 2024; 16(12): 10512 doi: 10.18632/aging.205945
|
| 4 |
Jennifer Duffen, Melvin Zhang, Katherine Masek-Hammerman, Angela Nunez, Agnes Brennan, Jessica E. C. Jones, Jeffrey Morin, Karl Nocka, Marion Kasaian. Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2. The Journal of Immunology 2018; 200(4): 1347 doi: 10.4049/jimmunol.1701256
|
| 5 |
Olena Zaitseva, Annett Hoffmann, Christoph Otto, Harald Wajant. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.935086
|